FDA’s revised MAPP outlines procedures for generic drug labeling changes
Regulatory NewsJoanne S. Eglovitch
Advertising, Promotion and LabelingNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchAdvertising, Promotion and LabelingNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy